[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=7562a04219b56724dc04d3fe0c51012cda4c8f9e3c78e0d857679451d50d8c37",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732898760,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "id": 131780007,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=7562a04219b56724dc04d3fe0c51012cda4c8f9e3c78e0d857679451d50d8c37"
    }
  },
  {
    "ts": null,
    "headline": "Galderma Bets on Skin Drug to Turn Around Pharma Business",
    "summary": "Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations.",
    "url": "https://finnhub.io/api/news?id=7d506eac6c36635577ff1987f81204851e80c7f95849e17679e8a0599da2366c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732898160,
      "headline": "Galderma Bets on Skin Drug to Turn Around Pharma Business",
      "id": 131710886,
      "image": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations.",
      "url": "https://finnhub.io/api/news?id=7d506eac6c36635577ff1987f81204851e80c7f95849e17679e8a0599da2366c"
    }
  }
]